Comparison Therapeutic Effects of Ciprofloxacin, Silver Nanoparticles and Their Combination in the Treatment of Pseudomonas keratitis in Rabbit: An Experimental Study

Pseudomonas aeruginosa is one of the most common causes of keratitis. The current study was done to evaluate the therapeutic effects of antibacterial combinations with Silver nanoparticles (Ag-NPs) and Ciprofloxacin in experimental Pseudomonas keratitis. Sixty four New Zealand rabbits were prepared. All rabbits were randomly categorized into eight groups (each group containing eight rabbits): Control +, Control −, Ciprofloxacin, Ag-NPs, Ciprofloxacin plus Betamethasone, Ag-NPs plus Betamethasone, Ciprofloxacin plus Ag-NPs, and Ciprofloxacin plus Ag-NPs plus Betamethasone. Twelve hours after bacterial inoculation into the cornea, the eyes were examined daily to evaluate the number of days of ocular discharge and blepharospasm. Also, after 108 and 204 h, first grading of corneal opacity was done and then four rabbits of each groups were euthanized for bacterial count. The results showed that the means of days of blepharospasm, ocular discharge, and bacterial counts (log CFU mL-1) were significantly different in the treatment groups at 108 and 204 h (P <0.0005, ANOVA). According to Tukey’s test, Ciprofloxacin plus Ag-NPs plus Betamethasone group was significantly less than Control +, Ag-NPs, and Ag-NPs plus Betamethasone groups for these variables (P < 0.05). The mean rank of opacity scores was significantly different between treatment groups (P = 0.01, Kruskal-Wallis). Mann-Whitney U-test revealed that Ciprofloxacin plus Ag-NPs plus Betamethasone group had significantly better score than Control +, Ag-NPs, and Ag-NPs plus Betamethasone groups (P < 0.05). It seems Ag-NPs can be an appropriate adjuvant for Ciprofloxacin, but due to the results they can’t be an alternative for Ciprofloxacin to treat Pseudomonas keratitis.

[1]  M. Saravanan,et al.  Green synthesis of silver nanoparticles using Rheum palmatum root extract and their antibacterial activity against Staphylococcus aureus and Pseudomonas aeruginosa , 2017, Artificial cells, nanomedicine, and biotechnology.

[2]  A. M. Barbosa,et al.  Silver Nanocomposite Biosynthesis: Antibacterial Activity against Multidrug-Resistant Strains of Pseudomonas aeruginosa and Acinetobacter baumannii , 2016, Molecules.

[3]  M. Hesaraki,et al.  Evaluation of the Antimicrobial Activity of Silver Nanoparticles on Antibiotic-Resistant Pseudomonas aeruginosa , 2016 .

[4]  Jinlai Zhao,et al.  Silver nanoparticles well-dispersed in amine-functionalized, one-pot made vesicles as an effective antibacterial agent. , 2016, Materials science & engineering. C, Materials for biological applications.

[5]  S. Das,et al.  Antibacterial Effects of Biosynthesized Silver Nanoparticles on Surface Ultrastructure and Nanomechanical Properties of Gram-Negative Bacteria viz. Escherichia coli and Pseudomonas aeruginosa. , 2016, ACS applied materials & interfaces.

[6]  D. Bhattacharya,et al.  Green and ecofriendly synthesis of silver nanoparticles: Characterization, biocompatibility studies and gel formulation for treatment of infections in burns. , 2016, Journal of photochemistry and photobiology. B, Biology.

[7]  M. Ahangarzadeh Rezaee,et al.  Emergence of colistin resistant Pseudomonas aeruginosa at Tabriz hospitals, Iran , 2016, Iranian journal of microbiology.

[8]  M. Havrdová,et al.  Strong and Nonspecific Synergistic Antibacterial Efficiency of Antibiotics Combined with Silver Nanoparticles at Very Low Concentrations Showing No Cytotoxic Effect , 2015, Molecules.

[9]  Mansi Sharma,et al.  Antimicrobial potentials of Helicteres isora silver nanoparticles against extensively drug-resistant (XDR) clinical isolates of Pseudomonas aeruginosa , 2015, Applied Microbiology and Biotechnology.

[10]  E. Bielanska,et al.  Charge Stabilized Silver Nanoparticles Applied as Antibacterial Agents. , 2015, Journal of nanoscience and nanotechnology.

[11]  F. Mirzaei,et al.  Antibacterial Effect of Allicin, Silver Nano Particles, and Their Combination against Skin Infection due to Pseudomonas aeruginosa in Animal Model , 2014 .

[12]  J. Yadav,et al.  Green silver nanoparticles of Phyllanthus amarus: as an antibacterial agent against multi drug resistant clinical isolates of Pseudomonas aeruginosa , 2014, Journal of Nanobiotechnology.

[13]  W. Petroll,et al.  Pseudomonas aeruginosa infectious keratitis in a high oxygen transmissible rigid contact lens rabbit model. , 2014, Investigative ophthalmology & visual science.

[14]  C. Khursigara,et al.  Synergy of Silver Nanoparticles and Aztreonam against Pseudomonas aeruginosa PAO1 Biofilms , 2014, Antimicrobial Agents and Chemotherapy.

[15]  A. L. Höfling-Lima,et al.  Evaluation of conjunctival bacterial flora in patients with Stevens-Johnson Syndrome , 2014, Clinics.

[16]  R. Durairaj,et al.  Antibiofilm properties of chemically synthesized silver nanoparticles found against Pseudomonas aeruginosa , 2014, Journal of Nanobiotechnology.

[17]  Robert E W Hancock,et al.  Pseudomonas aeruginosa: new insights into pathogenesis and host defenses. , 2013, Pathogens and disease.

[18]  Lilian Gonzalez,et al.  Nanotechnology in corneal neovascularization therapy--a review. , 2013, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[19]  S. Prabhu,et al.  Silver nanoparticles: mechanism of antimicrobial action, synthesis, medical applications, and toxicity effects , 2012, International Nano Letters.

[20]  R. Yeluri,et al.  Evaluation of minimum inhibitory and minimum bactericidal concentration of nano-silver base inorganic anti-microbial agent (Novaron®) against streptococcus mutans , 2012, Contemporary clinical dentistry.

[21]  D. Glidden,et al.  Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment. , 2012, Investigative ophthalmology & visual science.

[22]  Hongmei Wu,et al.  Antimicrobial activity and the mechanism of silver nanoparticle thermosensitive gel , 2011, International journal of nanomedicine.

[23]  Michael R Hamblin,et al.  Synergistic Combination of Chitosan Acetate with Nanoparticle Silver as a Topical Antimicrobial: Efficacy against Bacterial Burn Infections , 2011, Antimicrobial Agents and Chemotherapy.

[24]  A. Al-Mujaini,et al.  Bacterial keratitis: perspective on epidemiology, clinico-pathogenesis, diagnosis and treatment. , 2009, Sultan Qaboos University medical journal.

[25]  N. Azarpira,et al.  Amniotic Membrane Transplantation for the Treatment of Pseudomonas Keratitis in Experimental Rabbits , 2009 .

[26]  A. Ingle,et al.  Fabrication of silver nanoparticles by Phoma glomerata and its combined effect against Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus , 2009, Letters in applied microbiology.

[27]  P. Cornelis,et al.  Pyocin S2 (Sa) Kills Pseudomonas aeruginosa Strains via the FpvA Type I Ferripyoverdine Receptor , 2007, Journal of bacteriology.

[28]  C. Tamer,et al.  Comparative trial of different anti-bacterial combinations with propolis and ciprofloxacin on Pseudomonas keratitis in rabbits. , 2007, Microbiological research.

[29]  P. Thomas,et al.  Comparison of topical gatifloxacin 0.3% and ciprofloxacin 0.3% for the treatment of bacterial keratitis. , 2006, American journal of ophthalmology-glaucoma.

[30]  M. Takahata,et al.  Synthesis, antibacterial activity, and toxicity of 7-(isoindolin-5-yl)-4-oxoquinoline-3-carboxylic acids. Discovery of the novel des-F(6)-quinolone antibacterial agent garenoxacin (T-3811 or BMS-284756). , 2011, Arzneimittel-Forschung.

[31]  J. Niederkorn.  The immune privilege of corneal allografts. , 1999, Transplantation.